MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
|Podcasts|May 14, 2017
Health Plans and Healthcare Transformation: Mandi Bishop Interviews Dr Richard A. Bankowitz
Richard A. Bankowitz, MD, MBA, FACP, executive vice president for clinical affairs at America's Health Insurance Plans (AHIP) always had an affinity for data and early on in his career had an interest in using a data-driven approach to improve quality in healthcare. Throughout his career he has been dedicated to looking at safe and effective care and delivering affordable care.
Advertisement
Richard A. Bankowitz, MD, MBA, FACP, executive vice president for clinical affairs at America's Health Insurance Plans (AHIP) always had an affinity for data and early on in his career had an interest in using a data-driven approach to improve quality in healthcare. Throughout his career he has been dedicated to looking at safe and effective care and delivering affordable care.
Throughout his conversation with Mandi Bishop, MA, CEO and founder of Lifely Insights, Bankowitz discussed the role of insurers in facilitating healthcare transformation, how health plans can better address underlying causes that impact a person's ability to manage their health, the role of AHIP as a resource for health plans, and other topics.
Learn more about AHIP and what its members are doing at the
Listen below or through one of these podcast services:
iTunes:
TuneIn:
Stitcher:
Advertisement
Related to this article
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
This week in health equity and access: PMOS diagnosis, HIV lung cancer screening, transplant access, atopic dermatitis care, and value-based oncology.
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
3
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
4
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
5